Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS Treatment

NCT05382013 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Thrombocytopenia
Hepatitis B, Chronic
Acute-On-Chronic Liver Failure

Interventions

DRUG: Avatrombopag
OTHER: Artificial Liver Support System
OTHER: Comprehensive internal medical treatment.

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University